"Amikacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
Concept/Terms
Amikacina Medical- Amikacina Medical
- Medical, Amikacina
- Medical Brand of Amikacin Sulfate
Amikacina Normon- Amikacina Normon
- Normon, Amikacina
- Norman Brand of Amikacin Sulfate
Amikafur- Amikafur
- Fustery Brand of Amikacin Sulfate
Amikalem- Amikalem
- Lemery Brand of Amikacin Sulfate
Amikason's- Amikason's
- Son's Brand of Amikacin Sulfate
Amikayect- Amikayect
- Grossmann Brand of Amikacin Sulfate
Amikin- Amikin
- Amukin
- Mead Johnson Brand of Amikacin Sulfate
- Biclin
- Biklin
- Bristol-Myers Squibb Brand of Amikacin Sulfate
- Bristol Myers Squibb Brand of Amikacin Sulfate
- Amiklin
- Apothecon Brand of Amikacin Sulfate
BB-K8- BB-K8
- BB K8
- BBK8
- BB-K 8
- BB K 8
- BBK 8
Gamikal- Gamikal
- Galen Brand of Amikacin Sulfate
Kanbine- Kanbine
- Rovi Brand of Amikacin Sulfate
Oprad- Oprad
- Cryopharma Brand of Amikacin Sulfate
Yectamid- Yectamid
- Collins Brand of Amikacin Sulfate
A.M.K- A.M.K
- Pisa Brand of Amikacin Sulfate
Below are MeSH descriptors whose meaning is more general than "Amikacin".
Below are MeSH descriptors whose meaning is more specific than "Amikacin".
This graph shows the total number of publications written about "Amikacin" by people in Harvard Catalyst Profiles by year, and whether "Amikacin" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1995 | 1 | 1 | 2 |
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Amikacin" by people in Profiles.
-
Microbubble cavitation restores Staphylococcus aureus antibiotic susceptibility in vitro and in a septic arthritis model. Commun Biol. 2023 04 17; 6(1):425.
-
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex. Antimicrob Agents Chemother. 2021 10 18; 65(11):e0116421.
-
The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex. BMC Microbiol. 2020 10 19; 20(1):316.
-
Soft tissue infection caused by Mycolicibacter kumamotonensis. J Infect Chemother. 2020 Jan; 26(1):136-139.
-
Engraftment of Human Stem Cell-Derived Otic Progenitors in the Damaged Cochlea. Mol Ther. 2019 06 05; 27(6):1101-1113.
-
Outbreak of Hypervirulent Multidrug-resistant Klebsiella variicola Causing High Mortality in Neonates in Bangladesh. Clin Infect Dis. 2019 03 19; 68(7):1225-1227.
-
Influence of Spirulina platensis and ascorbic acid on amikacin-induced nephrotoxicity in rabbits. Environ Sci Pollut Res Int. 2019 Mar; 26(8):8080-8086.
-
Molecular-diversity, Prevalence and Antibiotic Susceptibility of Pathogenic Klebsiella Pneumoniae under Saudi Condition. Pak J Biol Sci. 2019 Jan; 22(4):174-179.
-
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet. 2018 09 08; 392(10150):821-834.
-
Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jun; 88(2):188-191.